摘要
目的:探讨注射用胸腺五肽辅助治疗慢性阻塞性肺病(COPD)伴低白蛋白血症患者的临床疗效。方法:选取确诊COPD伴低白蛋白血症的患者110例,随机分为A组(观察组,56例)和B组(对照组,54例)。A组在常规治疗的同时加用辅助治疗,B组用常规治疗,14d后观察两组患者症状缓解情况,比较两组患者在使用注射用胸腺五肽后的治疗效果。结果:两组患者接受治疗后病情都有明显改善,观察组患者的治疗有效率为92.86%,对照组患者的治疗有效率为77.78%,差异有统计学意义(x2=5.02,P<0.05)。结论:注射用胸腺五肽可增强COPD伴低白蛋白血症患者的免疫功能,改善患者症状,提高患者治疗效果。
Objective:To investigate efficacy of thymopentin in treatment of chronic obstructive pulmonary disease combined with hypoalbuminemia. Methods:110 cases with chronic obstructive pulmonary disease combined with hypoalbuminemia from January 2010 to December 2012 were randomly divided into A group ( observation group, 56 cases) and B group ( Control group, 54 cases) , A group was treated by thymopentin on the basis of conventional therapy, whereas B group was given the conventional treatment. 14 days later, the symptoms were observed and the treatment effects of the two groups were observed. Results:After the treatment, all had an obvious improvement. The effective rate of observation group was 92. 86%, while that of control group was 77. 78%, and the differ-ence was statistically significant (x2=5. 02, P<0. 05). Conclusions:Thymopentin can enhance immune function of chronic obstructive pulmonary disease combined with hypoalbuminemia, and improve the treatment effect.
出处
《中国民康医学》
2014年第7期14-15,共2页
Medical Journal of Chinese People’s Health
